Prenatal exposure to cocaine decreases adenylyl cyclase activity in embryonic mouse striatum

Developmental Brain Research

Volumn 147, Issue 1-2, 2003, Pages 67-75

  Unterwald, Ellen M ^a,b   Ivkovic, Sanja ^c   Cuntapay, Marie ^c   Stroppolo, Antonella ^d   Guinea, Barbara ^d   Ehrlich, Michelle E ^c,d,e  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adenylyl cyclase; cAMP; Cocaine; DARPP 32; Dopamine D1 receptor; Erk; In utero; Mouse; Ontogeny; Prenatal; FosB

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADENYLATE CYCLASE; COCAINE; FORSKOLIN; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; CORPUS STRIATUM; DEVELOPMENTAL STAGE; DRUG EFFICACY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FEMALE; MOUSE; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 1642534462     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(03)00058-0     Document Type: Article

References (87)

1. Akbari H.M., Kramer H.K., Whitaker-Azmitia P.M., Spear L.P., Azmitia E.C., Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res. 572:1992;57-63.
2. Antoni F.A., Molecular diversity of cyclic AMP signaling. Front. Neuroendocrinol. 21:2000;103-132.
3. Battaglia G., Cabrera T.M., Potentiation of 5-HT1A receptor-mediated neuroendocrine responses in male but not female rat progeny after prenatal cocaine: evidence for gender differences. J. Pharmacol. Exp. Ther. 271:1994;1453-1461.
4. bibb J.A., Chen J., Taylor J.R., Svenningsson P., Nishi A., Snyder G.L., Yan Z., Sagawa Z.K., Ouimet C.C., Nairn A.C., Nestler E.J., Greengard P., Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature. 410:2001;376-380.
5. Brent R.L., Relationship between uterine vascular clamping, vascular disruption syndrome, and cocaine teratogenicity. Teratology. 41:1990;757-760.
6. Brown B.L., Albano J.D.M., Ekins R.P., Sgherzi A.M., Tampion W., A simple and sensitive saturation assay method for measurement of adenosine 3′,5′-cyclic monophosphate. Biochem. J. 121:1971;561-562.
7. Brunzell D.H., Coy A.E., Ayres J.J., Meyer J.S., Prenatal cocaine effects on fear conditioning: exaggeration of sex-dependent context extinction. Neurotoxicol. Teratol. 24:2002;161-172.
8. Chai L., Choi W.S., Ronnekleiv O.K., Maternal cocaine treatment alters dynorphin and enkephalin mRNA expression in brains of fetal rhesus macaques. J. Neurosci. 17:1997;1112-1121.
9. Chen J., Kelz M.B., Hope B.T., Nakabeppu Y., Nestler E.J., Chronic Fos-related antigens: stable variants of ΔFosB induced in brain by chronic treatments. J. Neurosci. 17:1997;4933-4941.
10. Choi S.J., Mazzio E., Kolta M.G., Soliman K.F.A., Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain. Ann. NY Acad. Sci. 844:1998;293-302.
11. Clow D.W., Hammer R.P. Jr., Kirstein C.L., Spear L.P., Gestational cocaine exposure increases opiate receptor binding in weanling offspring. Dev. Brain Res. 59:1991;179-185.
12. Crandall J.E., Ren J.Q., Kosofsky B.E., Bhide P.G., Prenatal cocaine exposure decreases GABAergic populations in the developing mouse cerebral cortex. Soc. Neurosci. Abstr. 27:2001;248.15.
13. Daws L.C., Callaghan P.D., Moron J.A., Kahlig K.M., Shippenberg T.S., Javitch J.A., Galli A., Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem. Biophys. Res. Commun. 290:2002;1545-1550.
14. Deacon T.W., Pakzaban P., Isacson O., The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidence. Brain Res. 668:1994;211-219.
15. deCarlos J.A., Lopez-Mascaraque L., Valverde F., Dynamics of cell migration from the lateral ganglionic eminence in the rat. J. Neurosci. 16:1996;6146-6156.
16. Rodrigues P. dos S., Dowling J.E., Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C. Proc. Natl. Acad. Sci. USA. 87:1990;9693-9697.
17. Dow-Edwards D.L., Fico T.A., Hutchings D.E., Functional effects of cocaine given during critical periods of development. Teratology. 37:1988;518.
18. Dow-Edwards D.L., Freed L.A., Fico T.A., Structural and functional effects of prenatal cocaine exposure in adult rat brain. Dev. Brain Res. 57:1990;263-268.
19. Dow-Edwards D.L., Freed-Malen L.A., Gerkin L.M., Sexual dimorphism in the brain metabolic response to prenatal cocaine exposure. Dev. Brain Res. 129:2001;73-79.
20. Ehrlich M.E., Rosen N.L., Kurihara T., Shalaby I.A., Greengard P., DARPP-32 development in the caudate nucleus is independent of afferent input from the substantia nigra. Dev. Brain Res. 54:1990;257-263.
21. Ehrlich M.E., Sommer J., Canas E., Unterwald E.M., Periadolescent mice show enhanced ΔFosB upregulation in response to cocaine and amphetamine. J. Neurosci. 22:2002;9155-9159.
22. Elsworth J.D., Morrow B.A., Roth R.H., Prenatal cocaine exposure increases mesoprefrontal dopamine neuron responsivity to mild stress. Synapse. 42:2001;80-83.
23. Ferriero D.M., Dempsey D.A., Impact of addictive and harmful substances on fetal brain development. Curr. Opin. Neurol. 12:1999;161-166.
24. Fienberg A.A., Hiroi N., Mermelstein P.G., Song W., Snyder G.L., Nishi A., Cheramy A., O'Callaghan J.P., Miller D.B., Cole D.G., Corbett R., Haile C.N., Cooper D.C., Onn S.P., Grace A.A., Ouimet C.C., White F.J., Hyman S.E., Surmeier D.J., Girault J., Nestler E.J., Greengard P., DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science. 281:1998;838-842.
25. Foster G.A., Schultzberg M., Hokfelt T., Goldstin M., Hemmings H.C. Jr., Ouimet C.C., Walaas S.I., Greengard P., Ontogeny of the dopamine and cyclic adenosine-3′:5′-monophosphate-regulated phosphoprotein (DARPP-32) in the pre- and postnatal mouse central nervous system. Int. J. Dev. Neurosci. 6:1988;367-386.
26. Frank D.A., Augustyn M., Knight W.G., Pell T., Zuckerman B., Growth, development, and behavior in early childhood following prenatal cocaine exposure, a systematic review. J. Am. Med. Assoc. 285:2001;1613-1625.
27. Friedman E., Yadin E., Wang H.Y., Effect of prenatal cocaine on dopamine receptor-G protein coupling in mesocortical regions of the rabbit brain. Neuroscience. 70:1996;739-747.
28. Glatt S.J., Bolanos C.A., Trksak G.H., Jackson D., Effects of prenatal cocaine exposure on dopamine system development: a meta-analysis. Neurotoxicol. Teratol. 22:2000;617-629.
29. Gressens P., Kosofsky B.E., Evrard P., Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci. Lett. 140:1992;113-116.
30. Halladay A.K., Yue Y., Michna L., Widmer D.A., Wagner G.C., Zhou R., Regulation of EphB1 expression by dopamine signaling. Mol. Brain Res. 85:2000;171-178.
31. 3H]dopamine in rat brain tissue slices. Biochem. Pharmacol. 24:1975;847-852.
32. Henry D.J., White F.J., Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258:1991;882-889.
33. Heyser C.J., Miller J.S., Spear N.E., Spear L.P., Prenatal exposure to cocaine disrupts cocaine-induced conditioned place preference in rats. Neurotox. Teratol. 14:1992;57-64.
34. Hughes H.E., Donohue L.M., Dow-Edwards D.L., Prenatal cocaine exposure affects the acoustic startle response in adult rat. Behav. Brain Res. 75:1996;83-90.
35. Jones L.B., Fischer I., Levitt P., Nonuniform alterations of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cerebral Cortex. 6:1996;431-445.
36. Jones L.B., Stanwood G.D., Reinoso B.S., Washington R.A., Wang H.Y., Friedman E., Levitt P., In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J. Neurosci. 20:2000;4606-4614.
37. Keller Jr R.W., Snyder-Keller A., Prenatal cocaine exposure. Ann. NY Acad. Sci. 909:2000;217-232.
38. Kelz M.B., Chen J., Carlezon W.A. Jr., Whisler K., Gilden L., Beckmann A.M., Steffen C., et al. Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine. Nature. 401:1999;272-276.
39. Kosofsky B.E., Hyman S.E., No time for complacency: the fetal brain on drugs. J. Comp. Neurol. 435:2001;263-275.
40. Kosofsky B.E., Wilkins A.S., Gressens P., Evrard P., Transplacental cocaine exposure: a mouse model demonstrating neuroanatomic and behavioral abnormalities. J. Child Neurol. 9:1994;234-241.
41. Lauder J.M., Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci. 16:1993;233-239.
42. Leslie C.A., Robertson M.W., Jung A.B., Liebermann J., Bennett J.P. Jr., Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function. Synapse. 17:1994;210-215.
43. Lester B.M., LaGasse L.L., Seifer R., Cocaine exposure and children: the meaning of subtle effects. Science. 282:1998;633-634.
44. Letchworth S.R., Nader M.A., Smith H.R., Friedman D.P., Porrino L.J., Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 21:2001;2799-2807.
45. Lidow M.S., Prenatal cocaine exposure adversely affects development of the primate cerebral cortex. Synapse. 21:1995;332-341.
46. Lipton J.W., Robie H.C., Ling Z., Weese-Mayer D.E., Carvey P.M., The magnitude of brain dopamine depletion from prenatal cocaine exposure is a function of uterine position. Neurotox. Teratol. 20:1998;373-382.
47. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
48. Markowski V.P., Cox C., Weiss B., Prenatal cocaine exposure produces gender-specific motor effects in aged rats. Neurotoxicol. Teratol. 20:1998;43-53.
49. Matsuoka I., Suzuki Y., Defer N., Nakanishi H., Hanoune J., Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. J. Neurochem. 68:1997;498-506.
50. Mattson M.P., Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. Rev. 13:1988;179-212.
51. Mayes L.C., Granger R.H., Bornstein M.H., Zuckerman B., The problem of prenatal cocaine exposure, a rush to judgment. J. Am. Med. Assoc. 267:1992;406-408.
52. 35S]GTP γ S binding in the striatum and nucleus accumbens. Brain Res. Bull. 53:2000;147-152.
53. Mitchell E.S., Keller R.W. Jr., Snyder-Keller A., Immediate-early gene expression in concurrent prenatal ethanol- and/or cocaine-exposed rat pups: intrauterine differences in cocaine levels and Fos expression. Dev. Brain Res. 133:2002;141-149.
54. H.O. Morishima, R.A. Whittington, Species-, gender-, and pregnancy-related differences in the pharmacokinetics and pharmacodynamics of cocaine. In: P.V. Thadain (Ed.), Biological Mechanisms and Perinatal Exposure to Drugs, NIDA Research Monograph 158, NIDA, Maryland, 1995, pp. 2-21.
55. Morrow B.A., Elsworth J.D., Roth R.H., Prenatal cocaine exposure disrupts nonspatial, short-term memory in adolescent and adult male rats. Behav. Brain Res. 129:2002;217-223.
56. National Pregnancy and Health Survey: Drug Use Among Women Delivering Livebirths: 1992, National Institutes of Health, Publication No. 96-3819. 1996;NIH, Rockville, MD.
57. Nestler E.J., Barrot M., Self D.W., ΔFosB: a sustained molecular switch for addiction. Proc. Natl. Acad. Sci. USA. 98:2001;11042-11046.
58. Nye H.E., Hope B.T., Kelz M.B., Iadarola M., Nestler E.J., Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275:1995;1671-1680.
59. Olsen G.D., Potential mechanisms of cocaine-induced developmental neurotoxicity: a minireview. NeuroToxicology. 16:1995;159-168.
60. Pei J.M., Yu X.C., Fung M.L., Zhou J.J., Cheung C.S., Wong N.S., Leung M.P., Wong T.M., Impaired Gsα and adenylyl cyclase cause β-adrenoceptor desensitization in chronically hypoxic rat hearts. Am. J. Physiol. Cell Physiol. 279:2000;C1455-C1463.
61. Pilotte N.S., Sharpe L.G., Kuhar M.J., Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Ther. 269:1994;963-969.
62. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J., Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
63. Scalzo F.M., Ali S.F., Fambes N.A., Spear L.P., Weanling rats exposed prenatally to cocaine exhibit an increase in striatal D2 binding associated with an increase in ligand affinity. Pharmacol. Biochem. Behav. 37:1990;371-373.
64. Snyder-Keller A., Keller Jr R.W., Stimulant-mediated c-fos induction in striatum as a function of age, sex, and prenatal cocaine exposure. Brain Res. 794:1998;88-95.
65. Sobrian S.K., Burton L.E., Robinson N.L., Ashe W.K., James H., Stokes D.L., Turner L.M., Neurobehavioral and immunological effects of prenatal cocaine exposure in rat. Pharmacol. Biochem. Behav. 35:1990;617-629.
66. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., Uhl G.R., Cocaine reward models: conditioned place preference can be established in dopamine and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci., USA. 95:1998;7699-7707.
67. Spear L.P., Neurobehavioral consequences of gestational cocaine exposure: studies using a rodent model. Konkol R.J., Olsen G.D. Prenatal Cocaine Exposure. 1996;169-182 CRC Press, Boca Raton, FL.
68. Stanwood G.D., Washington R.A., Shumsky J.S., Levitt P., Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience. 106:2001;5-14.
69. Sun L.S., Perinatal cocaine exposure impairs myocardial β-adrenoceptor signaling in the neonatal rat. Anesth. Analg. 90:2000;50-56.
70. Tamamaki N., Fujimori K.E., Takauji R., Origin and route of tangentially migrating neurons in the developing neurocortical intermediate zone. J. Neurosci. 17:1997;8313-8323.
71. Terwilliger R., Beitner-Johnson D., Sevarino K.A., Crain S.M., Nestler E.J., A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:1991;100-108.
72. Todtenkopf M.S., De Leon K.R., Stellar J.R., Repeated cocaine treatment alters tyrosine hydroxylase in the rat nucleus accumbens. Brain Res. Bull. 52:2000;407-411.
73. Unterwald E.M., Cox B.M., Kreek M.J., Cote T.E., Izenwasser S., Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse. 15:1993;33-38.
74. Unterwald E.M., Fillmore J., Kreek M.J., Chronic repeated cocaine administration increases D1 dopamine receptor mediated signal transduction. Eur. J. Pharmacol. 318:1996;31-35.
75. Unterwald E.M., Ho A., Rubenfeld J.M., Kreek M.J., Time course of the development of sensitization and dopamine receptor upregulation during binge cocaine administration. J. Pharmacol. Exp. Ther. 270:1994;1387-1397.
76. Report to the Chairman, Committee on Finance, US Senate, Drug Exposed Infants, A Generation at Risk. 1990;US GAO, Washington, DC.
77. Valjent E., Corvol J.C., Pages C., Besson M.J., Maldonado R., Caboche J., Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20:2000;8701-8709.
78. Walker A., Rosenberg M., Balaban-Gil K., Neurodevelopmental and neurobehavioral sequelae of selected substances of abuse and psychiatric medications in utero. Child Adolesc. Psychiatr. Clin. N. Am. 8:1999;845-867.
79. Wang H.Y., Runyan S., Yadin E., Friedman E., Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins. J. Pharmacol. Exp. Ther. 273:1995;492-498.
80. Wang H.Y., Yeung J.M., Friedman E., Prenatal cocaine exposure selectively reduces mesocortical dopamine release. J. Pharmacol. Exp. Ther. 273:1995;1211-1215.
81. Wiggins R.C., Ruiz B.C., Development under the influence of cocaine. I: A comparison of the effects of cocaine treatment and resultant undernutrition on pregnancy and early growth in a large population of rats. Metab. Brain Dis. 5:1990;85-89.
82. Woods J.R., Cardiovascular effects of cocaine in pregnancy and on the fetus. NIDA Res. Monogr. 119:1992;111-115.
83. Xu M., Xiu-Ti H., Cooper D.C., Moratalla R., Graybiel A.M., White F.J., Tonegawa S., Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in D1 receptor mutant mice. Cell. 79:1994;945-955.
84. Yan Q.S., Reduced serotonin release and serotonin uptake sites in the rat nucleus accumbens and striatum after prenatal cocaine exposure. Brain Res. 929:2002;59-69.
85. Yue Y., Widmer D.A., Halladay A.K., Cerretti D.P., Wagner G.C., Dreyer J.L., Zhou R., Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. J. Neurosci. 19:1999;2090-2102.
86. Zachariou V., Benoit-Marand M., Allen P.B., Ingrassia P., Fienberg A.A., Gonon F., Greengard P., Picciotto M.R., Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP-32 or inhibitor 1. Biol. Psychiatry. 51:2002;612-620.
87. Zhen X., Torres C., Wang H.Y., Friedman E., Prenatal exposure to cocaine disrupts D1A dopamine receptor function via selective inhibition of protein phosphatase 1 pathway in rabbit frontal cortex. J. Neurosci. 21:2001;9160-9167.